Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tyrosine kinase inhibitor
Most Correlated Studies
- Dermal fibroblasts treated with the tyrosine kinase inhibitor erlotinib
- Kit225 human leukemia cells treated with NC1153 JAK3 tyrosine kinase inhibitor
- Lung cancer PC9 cells with tolerance or sensitivity to EGFR tyrosine kinase inhibitor gefitinib
- A375, A549, H3122, PC-9, NCI-N87 and RT-112 cells treated with THZ1 and/or tyrosine kinase inhibitor
- Gastric cancer GTL16 and lung cancer EBC-1 cells resistant to tyrosine kinase inhibitor crizotinib
Most Relevant Literature
- The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protei…
- Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatme…
- Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2.
- Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-i…
- Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squ…
Most Relevant Clinical Trials
- A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
- Effects of Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
- A Study for Tyrosine Kinase Inhibitors Discontinuation
- Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor
- Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility
